Celecoxib vs Durvalumab

Celecoxib vs Durvalumab: Overview

This comparison examines the pharmacological differences between Celecoxib and Durvalumab.

Mechanism of Action

Celecoxib: Selective COX-2 inhibitor.

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Pharmacokinetics

Half-life: Celecoxib — 11 hours; Durvalumab — 17 days.

Chemical Properties

Molecular Formula: Celecoxib — C17H14F3N3O2S.

Molecular Weight: Celecoxib — 381.3730 g/mol.

Type: Celecoxib — Small molecule; Durvalumab — Antibody.